(Q33699761)

28 July 2017

1 reference

title

Clinical epidemiology of acute myocardial infarction (English)

1 reference

28 July 2017

1 reference

Tavazzi L

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

published in

American Heart Journal

1 reference

28 July 2017

volume

138

1 reference

28 July 2017

issue

2 Pt 2

1 reference

28 July 2017

page(s)

S48-54

1 reference

Mortality by cause for eight regions of the world: Global Burden of Disease Study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Death rates from coronary disease--progress and a puzzling paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Thrombolysis for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Beta-Blockers after Myocardial Infarction — For Few Patients, or Many?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

ACE inhibitors in acute myocardial infarction: patient selection and timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Prognosis during one year of follow-up after acute myocardial infarction with emphasis on morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Factors associated with rehospitalization in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE Study). Cardiac Arrest in Seattle: Conventional Amiodarone Drug Evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Use of Cardiac Procedures and Outcomes in Elderly Patients with Myocardial Infarction in the United States and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Improving long-term survival of patients with acute myocardial infarction from 1977-1988 in a region of Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Improved long-term prognosis after myocardial infarction 1984-1991.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Acute respiratory-tract infections and risk of first-time acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

Seasonal Distribution of Acute Myocardial Infarction in the Second National Registry of Myocardial Infarction 11The National Registry of Myocardial Infarction is supported by Genentech, Inc., South San Francisco, California. Genentech, Inc. reimburse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970320-0

10.1016/S0002-8703(99)70320-0

7 January 2021

Identifiers

DOI

1 reference

release_nwvrtblrj5cvxjgyq4ocbnfn4a

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nwvrtblrj5cvxjgyq4ocbnfn4a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference